These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 38866081)
1. Chemodynamic therapy combined with endogenous ferroptosis based on "sea urchin-like" copper sulfide hydrogel for enhancing anti-tumor efficacy. Li S; Wang B; Tao J; Dong Y; Wang T; Zhao X; Jiang T; Zhang L; Yang H Int J Pharm; 2024 Jul; 660():124330. PubMed ID: 38866081 [TBL] [Abstract][Full Text] [Related]
2. Dendrimer/metal-phenolic nanocomplexes encapsulating CuO Huang H; Guo H; Liu J; Ni C; Xia L; Cao X; Xia J; Shi X; Guo R Acta Biomater; 2024 Jul; 183():252-263. PubMed ID: 38801869 [TBL] [Abstract][Full Text] [Related]
3. A nanoreactor boosts chemodynamic therapy and ferroptosis for synergistic cancer therapy using molecular amplifier dihydroartemisinin. Yang XX; Xu X; Wang MF; Xu HZ; Peng XC; Han N; Yu TT; Li LG; Li QR; Chen X; Wen Y; Li TF J Nanobiotechnology; 2022 May; 20(1):230. PubMed ID: 35568865 [TBL] [Abstract][Full Text] [Related]
4. A strategy of "adding fuel to the flames" enables a self-accelerating cycle of ferroptosis-cuproptosis for potent antitumor therapy. Huang L; Zhu J; Wu G; Xiong W; Feng J; Yan C; Yang J; Li Z; Fan Q; Ren B; Li Y; Chen C; Yu X; Shen Z Biomaterials; 2024 Dec; 311():122701. PubMed ID: 38981152 [TBL] [Abstract][Full Text] [Related]
5. A Triple-Responsive Polymeric Prodrug Nanoplatform with Extracellular ROS Consumption and Intracellular H Li Y; Cao Y; Ma K; Ma R; Zhang M; Guo Y; Song H; Sun N; Zhang Z; Yang W Adv Healthc Mater; 2024 Jun; 13(16):e2303568. PubMed ID: 38319010 [TBL] [Abstract][Full Text] [Related]
6. A ROS storm generating nanocomposite for enhanced chemodynamic therapy through H Li Y; Wang J; Zhu T; Zhan Y; Tang X; Xi J; Zhu X; Zhang Y; Liu J Nanoscale; 2024 May; 16(17):8479-8494. PubMed ID: 38590261 [TBL] [Abstract][Full Text] [Related]
7. A ferroptosis amplifier based on triple-enhanced lipid peroxides accumulation strategy for effective pancreatic cancer therapy. Chen M; Tong X; Sun Y; Dong C; Li C; Wang C; Zhang M; Wen Y; Ye P; Li R; Wan J; Liang S; Shi S Biomaterials; 2024 Sep; 309():122574. PubMed ID: 38670032 [TBL] [Abstract][Full Text] [Related]
8. Degradable iron-rich mesoporous dopamine as a dual-glutathione depletion nanoplatform for photothermal-enhanced ferroptosis and chemodynamic therapy. Cheng H; He Y; Lu J; Yan Z; Song L; Mao Y; Di D; Gao Y; Zhao Q; Wang S J Colloid Interface Sci; 2023 Jun; 639():249-262. PubMed ID: 36805750 [TBL] [Abstract][Full Text] [Related]
9. Fe-MnO Huang D; Xu D; Chen W; Wu R; Wen Y; Liu A; Lin L; Lin X; Wang X Biomed Pharmacother; 2023 May; 161():114431. PubMed ID: 36827713 [TBL] [Abstract][Full Text] [Related]
10. Tumor-Generated Reactive Oxygen Species Storm for High-Performance Ferroptosis Therapy. Huang L; Zhu J; Xiong W; Feng J; Yang J; Lu X; Lu Y; Zhang Q; Yi P; Feng Y; Guo S; Qiu X; Xu Y; Shen Z ACS Nano; 2023 Jun; 17(12):11492-11506. PubMed ID: 37283506 [TBL] [Abstract][Full Text] [Related]
11. In situ hydrogel based on Cu-Fe Zhang Y; Zhang N; Xing J; Sun Y; Jin X; Shen C; Cheng L; Wang Y; Wang X Biomaterials; 2024 Dec; 311():122675. PubMed ID: 38943822 [TBL] [Abstract][Full Text] [Related]
13. Sorafenib-Loaded Copper Peroxide Nanoparticles with Redox Balance Disrupting Capacity for Enhanced Chemodynamic Therapy against Tumor Cells. Chen C; Tan Y; Xu T; Sun Y; Zhao S; Ouyang Y; Chen Y; He L; Liu X; Liu H Langmuir; 2022 Oct; 38(40):12307-12315. PubMed ID: 36154182 [TBL] [Abstract][Full Text] [Related]
14. Nitric oxide-mediated regulation of mitochondrial protective autophagy for enhanced chemodynamic therapy based on mesoporous Mo-doped Cu Zhou Z; Gao Z; Chen W; Wang X; Chen Z; Zheng Z; Chen Q; Tan M; Liu D; Zhang Y; Hou Z Acta Biomater; 2022 Oct; 151():600-612. PubMed ID: 35953045 [TBL] [Abstract][Full Text] [Related]
15. Self-Assembling Porphyrins as a Single Therapeutic Agent for Synergistic Cancer Therapy: A One Stone Three Birds Strategy. Chen J; Chen F; Zhang L; Yang Z; Deng T; Zhao Y; Zheng T; Gan X; Zhong H; Geng Y; Fu X; Wang Y; Yu C ACS Appl Mater Interfaces; 2021 Jun; 13(24):27856-27867. PubMed ID: 34110146 [TBL] [Abstract][Full Text] [Related]
16. Metal-polyphenol self-assembled nanodots for NIR-II fluorescence imaging-guided chemodynamic/photodynamic therapy-amplified ferroptosis. Zhu Y; Ding C; Fang W; Li T; Yan L; Tian Y; Huang W; Wei P; Ma J; Lin X; Huang W; Lin Y; Zou J; Chen X Acta Biomater; 2024 Sep; 185():361-370. PubMed ID: 39025392 [TBL] [Abstract][Full Text] [Related]
17. Self-Assembled Copper-Based Nanoparticles for Glutathione Activated and Enzymatic Cascade-Enhanced Ferroptosis and Immunotherapy in Cancer Treatment. Song WF; Zeng JY; Ji P; Han ZY; Sun YX; Zhang XZ Small; 2023 Aug; 19(35):e2301148. PubMed ID: 37118853 [TBL] [Abstract][Full Text] [Related]
18. Cisplatin-activated and hemoglobin-mediated injectable hydrogel system for antitumor chemodynamic and chemotherapy. Tsen HT; Sun TC; Lai TK; Huang WY; Wang HC; Lu TT; Wang TW Biomed Pharmacother; 2024 Jun; 175():116713. PubMed ID: 38735083 [TBL] [Abstract][Full Text] [Related]
19. Glutathione/pH-responsive copper-based nanoplatform for amplified chemodynamic therapy through synergistic cycling regeneration of reactive oxygen species and dual glutathione depletion. Jia S; Ke S; Tu L; Chen S; Luo B; Xiong Y; Li Y; Wang P; Ye S J Colloid Interface Sci; 2023 Dec; 652(Pt A):329-340. PubMed ID: 37597414 [TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-Derived ROS-Generating Nanomedicine with pH-Modulated Degradability to Enhance Tumor Ferroptosis Therapy and Chemotherapy. Xu M; Zha H; Han R; Cheng Y; Chen J; Yue L; Wang R; Zheng Y Small; 2022 May; 18(20):e2200330. PubMed ID: 35451223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]